Clinical Trial Update: The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of topical valproic acid to prevent hair loss in androgenetic alopecia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Topical valproic acid (valproic acid)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Androgenetic Alopecia, Male Pattern Baldness | Phase 2 | Status: COMPLETED